Raymond James Financial
PLSE icon

Raymond James Financial’s Pulse Biosciences PLSE Stock Holding History

Raymond James Financial’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-990
Closed -$14.9K – 6272
2025
Q2 		$14.9K Buy
+990
New +$16.4K ﹤0.01% 5725

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial's PLSE Position: Q3 2025 in Review

Raymond James Financial sold out of Pulse Biosciences (PLSE) in Q3 2025, closing a stake of 990 shares — an estimated $14.9K sold.

Raymond James Financial first reported a position in PLSE in Q2 2025 and held it in 1 quarter. The position peaked at $14.9K in Q2 2025. 84 funds tracked by Wall St. Rank hold PLSE as of Q3 2025.

  • Raymond James Financial reported no remaining Pulse Biosciences position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 990 Pulse Biosciences shares in Q3 2025, an estimated $14.9K.
  • Raymond James Financial first reported a position in Pulse Biosciences in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Pulse Biosciences position peaked at $14.9K in Q2 2025.
  • 84 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.